Etesian Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.03M Sell
3,360
-67
-2% -$68.5K 1.19% 26
2026
Q1
$3.15M Sell
3,427
-132
-4% -$134K 1.01% 28
2025
Q4
$3.82M Sell
3,559
-38
-1% -$36.3K 1.2% 24
2025
Q3
$2.74M Sell
3,597
-85
-2% -$63.3K 0.91% 27
2025
Q2
$2.87M Sell
3,682
-4
-0.1% -$3.11K 1.07% 24
2025
Q1
$3.04M Sell
3,686
-215
-6% -$179K 1.31% 19
2024
Q4
$3.01M Sell
3,901
-96
-2% -$79.5K 1.33% 19
2024
Q3
$3.54M Sell
3,997
-56
-1% -$50.3K 1.6% 15
2024
Q2
$3.67M Sell
4,053
-108
-3% -$86.4K 2.06% 11
2024
Q1
$3.24M Sell
4,161
-136
-3% -$96.8K 1.86% 12
2023
Q4
$2.5M Sell
4,297
-232
-5% -$135K 1.5% 20
2023
Q3
$2.43M Sell
4,529
-479
-10% -$247K 1.64% 14
2023
Q2
$2.35M Sell
5,008
-93
-2% -$39K 1.53% 17
2023
Q1
$1.75M Sell
5,101
-74
-1% -$25K 1.17% 28
2022
Q4
$1.89M Buy
+5,175
New +$1.83M 1.38% 21

Other funds holding LLY

Etesian Wealth Advisors's LLY Position: Q2 2026 in Review

Etesian Wealth Advisors reduced its Eli Lilly (LLY) stake by 2% in Q2 2026, selling an estimated $68.5K and leaving 3,360 shares worth $4.03M. The position accounts for 1.19% of the portfolio, ranked #26.

Etesian Wealth Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Etesian Wealth Advisors held 3,360 shares of Eli Lilly worth $4.03M as of Q2 2026.
  • Etesian Wealth Advisors sold 67 Eli Lilly shares in Q2 2026, an estimated $68.5K.
  • Eli Lilly made up 1.19% of Etesian Wealth Advisors's portfolio in Q2 2026, its #26 holding.
  • Etesian Wealth Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Etesian Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.